Within the other three pathways (ECM-receptor interaction, TGFβ, and cell cycle), the miRNAs showed different trends and, therefore, a progressive increase or decrease in expression from AF-MSCs to L-MSCs, i.e., along the hypothetical differentiation process, could not be deduced. The gene discussed is TGFB1; the disease is atrial fibrillation.